Dear respected authors,
if you can't find our response then please search our mail in your spam box and communicate with us to the following mail as well: sakaijuro45@gmail.com
Submission Deadline
Volume -
63
, Issue
02
30 Jan 2023
Day
Hour
Min
Sec
Submit Now
Upcoming Publication
Volume -
63
, Issue
01
31 Jan 2023
Azerbaijan Medical Journal
(ISSN: 0005-2523)Azerbaijan medical journal (ISSN: 0005-2523) - is a scopus indexed journal since 1961. The publisher of the journal is Izdatel'stvo Elm by WHO Office in Azerbaijan. Azerbaijan medical journal (AMJ) is also UGC approved. The journal publishes general medicine, health science, psychological, pharmaceutical journals and so on.
Aim and Scope
Azerbaijan Medical Journal
Azerbaijan Medical Journal (ISSN: 0005-2523) - is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to.
Latest Journals
Azerbaijan Medical Journal
IMMUNOHISTOCHEMICAL INVESTIGATION OF HORMONAL RECEPTORS IN ENDOMETRIUM OF LADIES WITH USELESS UTERINE DYING: A PLANNED CROSS-SECTIONAL EXAMINATION AT A TERTIARY CENTER
Dysfunctional uterine bleeding is a major gynecologic hassle, with numerous remedy options. A good sized percentage of these sufferers go through hysterectomy. to analyze the hormonal milieu at the tissue degree, we semi-quantitatively assessed the estrogen and progesterone receptors in the endometrial samples of fifty DUB sufferers, by way of Immunohistochemistry. We observed a big boom (p < 0.001) within the concentration of both estrogen and progesterone receptors in patients with dysfunctional uterine bleeding, in comparison to the regular populace. We also mentioned a substantial growth inside the endometrial thickness (p < 0.001) of sufferers with easy endometrial hyperplasia. Our look at demonstrates the position of estrogen and progesterone receptors in the etiopathogenesis of dysfunctional uterine bleeding and within the alteration within the morphology of endometrium, consisting of easy endometrial hyperplasia. We suggest the usage of progesterone antagonists and selective progesterone receptor modulators within the remedy of patients with dysfunctional uterine bleeding, especially in people with endometrial hyperplasia, who convey the longtime danger of endometrial carcinoma with sustained endometrial estrogenic stimulation